Serum Institute to manufacture India’s 1st vaccine against cervical cancer after DGCI nod
Cervical cancer is the second most frequent cancer among women in India between the ages of 15 and 44.
Written by Harshit Sabarwal | Edited by Sohini Goswami, New Delhi
The Drugs Controller General of India (DCGI) on Tuesday approved…